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Summary.-A crude membrane fraction isolated from mouse tumour cells was
treated with various chemicals. The effects on the immunogenicity of the membrane
sample were tested in syngeneic mice for tumour protection, using a challenge dose
of 105 viable tumour cells. Best protection was obtained after immunization of mice
with a membrane sample modified with dimethylsulphate. Up to 60% of the animals
remained tumour free, and the tumour-bearing animals showed a greatly increased
mean survival time. The post-challenge sera contained no detectable amounts of
cytotoxic antibodies.
The membrane sample isolated from tumour cells which had been modified with
dimethylsulphate showed less immunogenicity than the modified cells or the mem-
brane fraction from unmodified cells.
INVESTIGATIONS of the immunogenic
capacity of chemically modified proteins
have shown evidence for a fundamental
relationship between humoral and cell-
mediated immunity. Increasing aceto-
acetylation steadily reduced the ability
of flagellin to initiate the formation of
humoral antibodies specific for flagellin,
but enhanced the capacity to induce
flagellin-specific delayed-type hypersen-
sitivity and antibody tolerance (Parish,
1971a, b; 1973; Parish and Liew, 1972).
Similar results were obtained with bovine
serum albumin modified with dodecanoic
anhydride (Coon and Hunter, 1972) or
with methanol/hydrochloric acid (Schirr-
macher and Wigzell, 1972) as well as with
tobacco-mosaic virus modified with di-
methylsulphate (Staab and Anderer, 1976)
hen egg albumin modified with dodecanoic
anhydride (Champlin and Hunter, 1975)
and carcinoembryonic antigen modified by
acetoacetylation (Chao et al., 1973). Re-
duction and carboxymethylation of lyso-
zyme yielded a derivative which exhibited
excellent cross-reactivity in delayed skin
reactions, when tested with non-modified
lysozyme or vice versa. Lysozyme and its
derivative induced comparable humoral
responses, but cross-reactivity of anti-
bodies could not be established (Thomson
et al., 1972).
The numerous studies directed towards
influencing the immunogenicity oftumour
cells by chemical modification has been
reviewed by Prager and Baechtel (1973).
Immunizationofexperimentalanimalswith
modified tumour cells induced protection
against a challenge by homologous native
tumour cells, but the degree of protection
ranged from very high to very low, de-
pending on the cell lines, on the immuni-
zing doses and on the type of chemical
modification. However, immunizing with
modified tumour cells, although the cells
were no longer viable, implies a hazard
from still intact genetic information, for
instance of viruses or oncogenes. It is
desirable, therefore, to know more about
the effect of chemical modification on the
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immunogenic capacity ofsubcellular mem-
brane fractions. Chemical modification of
a crude membrane fraction of tumour
cells by dodecanoic anhydride shifted its
immunogenic capacity from enhancing to
suppressing tumour growth (Hunter and
Strickland, 1975).
In previous experiments (Staab and
Anderer, 1977) it could be shown that a
number of chemical modifiers altered the
immunogenicity of mouse sarcoma tumour
cells to greater protection against a
subsequent challenge with viable tumour
cells thanprovided by X-irradiated tumour
cells. The aim of the present study was
now to investigate the influence of these
chemical modifiers on the immunogenic
capacity of membrane fractions from the
same tumour cell line. Experimental
animals and tumour cells were syngeneic,
so that no interference due to differences
in the pattern of histocompatibility
antigens could be expected.
MATERIALS AND METHODS
Chemicals. 1 -Ethyl-3(3-dimethylamino-
propyl)-carbodiimide (EDC) was obtained
from the Ott Chemical Co., Muskegon,
Mich., USA. All other chemicals were of
analytical grade, and were obtained from
Merck, Darmstadt, Germany. [14C] nico-
tinamide (59 mCi/mmol) was purchased from
Amersham, England.
Cells-.The cell line STU-D 17 was ob-
tained from STU mouse embryo cells trans-
formed by Rous sarcoma virus (Schmidt-
Ruppin strain). The cell line was kindly
supplied by Dr Heinz Bauer, University of
Giessen, Germany. Specificity controls were
performed with foetal tissue of STU mice
prepared from decapitated and eviscerated
mouse embryos at end of term, and with
STU 51A/232B cells derived from SV40-
transformed STU embryo cells (Kulas et al.,
1972).
Cell cultures.-The cells w,ere grown in
minimum essential medium supplemented
with 10% of foetal calf serum (Dulbecco and
Freeman, 1959). The cells were harvested by
mechanical dislodgement and washed x 3 in
ice-cold phosphate-buffered saline (PBS).
Preparation of the crude membrane fraction.
-The washed cells were resuspended in
0 5 mM MgCl2. This procedure made the cells
swell to the 2-3-fold volume of packed cells.
Disruption of cells was performed in the
buffer solution using a Dounce homogenizer
in an ice bath. Generally, 10-20 strokes dis-
rupted 9000 of the cells. The cell homogenate
was centrifuged at 4°C and 400 g for 5 min
to remove nuclei and still-intact cells. The
resulting supernatant was layered on to a
discontinuous gradient of 10, 43 and 5000
sucrose solutions (w/w) of 3, 2 and 1 ml,
respectively. The gradient was centrifuged in
a Spinco rotor SW 40 at 10,000 rev/min and
4°C for 30 min. The membrane material
present in the zone between 13 and 4000
sucrose was collected and dialysed against
PBS at 4°C for 24 h. The dialysed crude
membrane fraction wNas used for chemical
modifications. The protein content of the
sample was determined by the method of
Lowry et al. (1951).
For the preparation of a crude foetal
membrane fraction the decapitated and
eviscerated mouse embryos were chopped and
pressed through a stainless-steel screen. After
treatment in a Dounce homogenizer, crude
particulate material was removed by sedi-
mentation at 400 g for 5 mi.
Preparations of crude membrane fractions
from chemically modified cells were carried
out as follows: The cells were washed x 3
with cold PBS after termination of the modi-
fication reaction, resuspended in 0-5 mM
MgCl2 containing 8-5% of sucrose, and
disrupted in a Dounce homogenizer. The
isolation of the crude membrane fractions
w-ere carried out as mentioned above but
using a discontinuous gradient of 30, 60 and
65% sucrose solutions.
Conditions of chemical modification.-The
chemical modification of cells with dimethyl-
sulphate was performed under standard
conditions as described previously (Staab
and Anderer, 1977). For the modification of
the crudemembrane fraction,onlythose chem-
ical modifiersAwere used which showed optimal
effects on the immunogenicity of intact cells.
Portions of the dialysed crude membrane
fraction, each corresponding to 5 x 107 cells
originally, were brought to a final volume of
5 ml with PBS and reacted with the given
concentrations of the following chemical
reagents: (a) 50 mm or 250 mm dimethyl-
sulphate at 37°C for 10 min; (b) 50 or 250 mm
acetic anhydride at 4°C for 10 min; (c)
250 mm dimethylsulphate at 37°C for 10 min,
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followed by thorough dialysis against PBS at
4°C for 6 h and incubation with methylamine
(600 or 3000 mM) at room temperature for
3 h; (d) 200 mm glutardialdehyde at room
temperature for 3 h, followed by thorough
dialysis against PBS and reaction with 50 mM
dimethylsulphate at 37°C for 10 min; (e)
200 mm glutardialdehyde at room tempera-
ture for 3 h, followed by thorough dialysis
against PBS and reaction with 20 mm EDC+
600 or 3000 mm methylamine. After termina-
tion of the reaction, all samples were tho-
roughly dialysed against PBS at 4°C over
night.
In addition, one portion of the crude
membrane fraction was treated with 300 mu
of neuraminidase from Cl. perfringens (Boeh-
ringer, Mannheim, Germany) according
to the outlines given by Vasudevan et al.
(1970).
To quantitate the final yield of the mem-
brane fractionswith respectto theoriginal cell
number, a sample of native cells was labelled
with 1251 by lactoperoxidase-catalysed iodi-
nation, according to the outlines given by
Hubbard and Cohn (1975) where 90% of the
label is localized on the cell surface. The
preparation of the crude membrane fraction,
as well as the steps of dialysis (but without
any chemical modification) were performed
as described above. The label found there-
after in the membrane fraction corresponded
to a yield of about 20%.
Immunization procedures.-Highly inbred
STU mice (Committee on standardized
nomenclature forinbred strains of mice, 1968)
4-6 weeks old were used in all experiments.
Each experimental group had equal numbers
of male and female animals. Groups of 10
animals were immunized, each with a single
s.c. injection (0-2 ml) into the left flank, with
doses of the modified membrane samples
correspondingf to 104, 102, 101 and 100 cells.
It should benoted that these relative amounts
of the membrane samples were corrected for
losses (about 80%) due to the procedures of
the membrane preparation. The amount of a
membrane sample corresponding to 105 cells
corrected for losses, contained between
8-8-10-5 ,ug of protein. This correction was
used to calculate the membrane equivalents
of the crude foetal membrane fraction.
Fourteen days after immunization, the mice
received a challenge of 105 viable STU-D 17
tumour cells (0-2 ml) s.c. into the neck.
These cells had been washed x3 with PBS
before application. Controls were 10 animals
per group receiving only a challenge of
viable tumour cells. The appearance of
tumours was observed over a period of 90
days.
Serology.-The mice were bled 7 days after
tumour challenge by puncturing the retro-
orbital sinus. The individual sera of each
group were pooled. Serum dilutions 1:20
were tested in a membrane permeability
assay (Kurth and Medley, 1975) using minor
modifications. Thecellnumberwasadjustedto
3 x 105 cells/ml and incubated with 7-5 ,uCi
[14C]nicotinamide/ml at 37°C for 2 days.
Tests were carried out in quadruples, with
separate controls of the preimmune sera,
medium, antisera and complement. Rabbit
complement was used in a dilution 1: 8
throughout. Radioactivity was determined
in a Packard scintillation counter. The
counting efficiency was 85%.
RESULTS
To overcome the hazard that immuniza-
tion with chemically modified tumour
cells might possibly still have intact
genetic information, we investigated the
immunogenic capacity of the membrane
fraction isolated from modified cells.
Modification of tumour cells with di-
methylsulphate appeared most promising
since in previous investigations (Staab
and Anderer, 1977) we found that, after
immunization with these modified cells,
30% of the animals remained tumour free
and the tumour-developing animals had a
greatly increased mean survival time
(183% of control). However, immunization
of mice with the isolated membrane
fraction of dimethylsulphate-modified
tumour cells did not induce comparable
immunity against the tumour transplant.
As shown in Table I all animals developed
tumours and the mean survival time
attained only 145% of the control.
Attempts to prepare membrane fractions
from cells modified with various other
chemicals proved to be very difficult.
Therefore, special emphasis was put on
the survey of various chemical modifica-
tions which were expected to improve the
immunogenic capacity of the membrane
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TABLE I.-Protection of STU mice against challenge with 105 STU-D 17 tumour cells
after pretreatment with various dosages of the modified crude membrane fractions of
STU-D 17 tumour cells or of the crude membrane fraction obtained from dimethyl-
sulphate-modified STU-D 17 tumour cells. The challenge was given 14 days after
immunization.
Treatment
Controls
Unmodified
Neuraminidase
Immunization
log cells*
per animal
4
2
1
0
4
2
1
0
Dimethylsulphate
(50 mM)
Acetic anhydride (50 mM)
Glutardialdehyde
+ (EDC + methylamine)
(20 mM + 3M)
Membranes from dimethylsulphate-
modified cells
4
2
1
0
4
2
1
0
% animals alive
30 50 70
days after challenge
70 30 0
100 50 20
100 60 10
100 50 20
70 30 0
90 50 0
100 20 10
100 50 10
90 20 0
90 80 60
100 100 60
100 50 10
70 20 0
90 50 40
100 70 30
100 70 0
80 20 0
4 90 60 30
2 90 60 60
1 90 70 10
0 70 60 0
4 100 70 10
2 100 30 0
Mean survivalt
days % of control
38 100
47 124
49 129
46 121
40 105
48 126
45 118
48 126
43 113
58 153
59 155
49 129
40 105
46 121
51 134
54 142
43 113
46
52
52
43
55
42
121
137
137
113
145
110
* Membrane equivalents corrected for losses; t Tumour-bearing animals; t No palpable tumours at 90
days.
fraction isolated from viable tumour cells.
Control immunizations were performed
with non-modified as well as with neur-
aminidase-treated membrane fractions.
To correlate with the most efficient
immunizing dosages of modified cells
previously reported (Staab and Anderer,
1977) we estimated the losses of membrane
material during membrane preparation,
and used for immunization only doses of
the modified-membrane fractions which
were corrected for these losses. In a
previous experiment (Staab and Anderer,
1977) the optimal immunizing dose was
found to be between 102 and 104 modified
cells. Therefore, immunization was now
carried out with membrane equivalents
corresponding to 104, 102, 101 and 100
cells. Thelatter values were predominantly
considered as controls to characterize the
trend ofinfinitesimal dilution. The amount
of membrane protein present in a mem-
brane equivalent of 101 cells was about
1 ng.
The tumour cells used for the challenge
were derived from one and the same pas-
sage, and exhibited an LD100 of 5 x 102
cells per animal. The challenge dosage of
105 viable tumour cells was given 14 days
after immunization. This interval was
found to be sufficient for inducing tumour
protection when immunization was car-
ried out with modified cells (Staab and
Anderer, 1977). In the course of the
experiment we determined the number of
animals which remained tumour free for
90 days after challenge with viable cells.
The mean survival time was calculated
only for those mice which developed
tumours. The resulting value, measured in
days or in percentage of the survival time
of the controls, represented an additional
Tumour-free
animalst
% per group
0
20
10
0
0
0
0
0
0
40
60
0
0
30
30
0
0
20
30
0
0
0
0
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criterion for induced immunity against the
tumour transplant. The results, together
with the number of living animals at
Days 30, 50 and 70 after the tumour
challenge are given in Table I. The data
of some experiments in which the modify-
ing conditions did not improve the immu-
nogenic capacity ofthe isolated membrane
fraction are not listed.
Immunization of mice with unmodified
membrane fractions showed at most up
to 20% of tumour-free animals, and only
a moderate increase in mean survival
time. This result is comparable to the
findings after immunization of mice with
X-irradiated tumour cells (Staab and
Anderer, 1977). Treatment of the mem-
brane fraction with neuraminidase did not
appear to increase the immunogenic
capacity of the sample. The best immuni-
zing effect was found with the membrane
fraction modified with dimethylsulphate
in a concentration of 50 mM. A 5-fold
increase in concentration of the modifying
reagent did not improve the immunogenic
capacity of the membrane sample. Up to
60% of the animals remained tumour free
and the mean survival time ofthe tumour-
bearing animals showed the highest in-
crease over the other experimental groups
of mice. Immunization with membrane
samples modified with acetic anhydride
as well as with glutardialdehyde/(EDC +
methylamine) induced a smaller but
still significant increase in immuno-
genicity. With doses of the membrane
samples corresponding to 102 and 104
tumour cells, up to 30% of the animals
remained tumour free thus exhibiting a
slightly better immunizing effect than
unmodified membrane samples. A 5-fold
increase in acetic anhydride concentration
during the modifying reaction did not
increase the immunogenicity of the result-
ing membrane sample. However, con-
sidering the concentrations ofthe reagents
of the complex modification with glutar-
dialdehyde/(EDC + methylamine), one
has to note that a reduction of the
methylamine concentration by a factor 5
led to a less immunogenic membrane
sample. In all experiments, no significant
differences in the distribution of tumours
between male and female animals were
observed.
The most effective doses of all the
modified-membrane samples were mem-
brane equivalents corresponding to 102-
104 tumour cells. There is a slight tendency
that membrane equivalents of 102 cells
were more effective in inducing immunity
against the tumour-cell transplant. Fur-
ther reduction of the immunizing dose,
however, abolished the immunizing effect.
Theimmunological specificity oftumour
protection could be demonstrated in a
number of control experiments. As a
non-cross-reacting tumour we used an
TABLE II.-Protection of STU mice against challenge with 105 STU-D 17 cells after
pretreatment with methylated or unmodifle'd membrane fractions from STU-D 17 cells
(transformned by RSV), from STU-51A/232B cells (transformed by SV 40) and from
STU embryonic tissue. The challenge was given 14 days after immunization with a
single dose equivalent to 104 cells.
Immunizing
membrane fraction
Saline buffer
STU-D 17
STU-D 17 methylated
STU 51A/232B
STU 51A/232B methylated
STU foetal tissue
STU foetal tissue methylated
% Animals alive
Tumour-free
30 50 70 Mean survival* animalst
days after challenge (% of control) (% per group)
100 50 0 100 0
100 50 20 112 0
100 100 60 131 40
100 60 0 103 0
100 80 0 110 0
100 60 0 98 0
100 70 0 109 0
* Tumour-bearing animals; t no palpable tumours at 90 days.
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SV 40-transformed cell line, STU 51A/
232B, also derived from embryonic cells of
STU mice. Since this cell line was grown
in the same culture medium as the STU-D
17 cells taken for challenge, the STU 51A/
232B membrane fraction could simul-
taneously serve as a control for possible
immunogenic effects induced by foetal
bovine serum components adhering to
the cells surface membranes. A crude
membrane fraction prepared from foetal
tissue of STU mouse embryos should give
information on the immunogenic effects of
foetal antigens. All these specificity con-
trols were performed only with male mice
to exclude non-specific effects based on
the presence of sex-linked antigens. The
membrane fractions were tested as un-
modified samples, as well as samples
modified with dimethyl sulphate.
The data listed in Table II again show
the highly significant effect of methylation
on the specific immunogenicity of the
STU-D 17 membrane fraction. Neither
immunization with the membrane fraction
of the non-cross-reacting tumour cell
line STU 51A/232B, nor with that derived
from foetal tissue, whether applied in the
unmodified or in the methylated form,
exhibited any influence on the growth of
the STU-D 17 tumour transplants or on
the survival of experimental animals.
Thus, one can conclude that the immuno-
genic effect of the methylated STU-D17
membrane fraction is tumour specific.
In order to characterize the type of
immune response induced by the modified
membrane fractions, a membrane-per-
meability assay (Kurth and Medley,
1975) was used to detect cytotoxic anti-
bodies. The preimmune sera represented
the negative controls, and a rabbit serum
obtained after immunization with STU-D
17 tumour cells was used as positive
control. In a final serum dilution 1:10
the positive control serum induced 70%o
membrane permeability, in a dilution
1: 20 permeability was 37%. All pooled
mouse sera obtained 7 days after the
tumour challenge were assayed in a final
serum dilution 1: 20. In all cases membrane
permeability was found to be less than
10% which indicated that the amount of
cytotoxic antibodies, if they are present
at all, must be very low.
DISCUSSION
The effects of the individual chemical
modifiers on the immunogenicity of the
membrane fraction of STU-D 17 tumour
cells correlate fairly well with the
effects previously observed after immuni-
zation with modified tumour cells (Staab
and Anderer, 1977). This finding opens up
the possibility of inducing comparable
tumour protection by immunization with-
out the risk of transnmitting biologically
hazardous genetic information. Optimal
tumour protection and increased survival
time were again found to depend on the
chemical nature of the modifying group
as well as on the dose of the immunizing
membrane fraction. Modification of the
membrane fraction with dimethylsulphate
induced the most efficient alteration of
immunogenicity as against the non-modi-
fied membrane sample. On the other hand,
best results were obtained with the lower
immunizing doses, i.e. with membrane
equivalents of 102 cells. The controls of
infinitesimal dilution of the immunizing
material clearly showed that tumour
protection was specifically bound to the
immunizing membrane sample. Theexperi-
mental manipulation of animals during
immunization scarcely has any effect,
since the survival time of all groups of
mice receiving a membrane dose equiva-
lent to 100 cells was comparable to that
of the non-immunized control group.
The membrane antigens responsible for
tumour rejection were found to be dis-
tinctly STU-D 17-tumour-specific. Im-
munogenic effects of contaminating anti-
gens derived from foetal bovine serum of
the culture medium, which might adhere
to the cell surface and remain adhered
during membrane preparation (Phillips
and Perdue, 1977) could be excluded. In
control experimentsthemembranefraction
of a non-cross-reacting tumour cell line,
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STU 51A/232B, grown in the same
culture medium did not induce any
tumour rejection. Neither did mouse
foetal antigens present on the surface of
STU-D 17 cells appear to participate in
tumour rejection, since immunization with
membrane fractions prepared from foetal
tissue did not influence the growth of
STU-D 17 tumour transplants. Sex-linked
surface antigens responsible for tumour
rejection can also be ruled out, since the
distribution of male and female animals
within the groups of survivors was about
equal.
The failure to produce an adequate
immune response observed with the mem-
brane fraction isolated from dimethyl-
sulphate-modified tumour cells, is difficult
to explain. A possible explanation is
offered by the assumption that methylated
cell membranes preferably form "inside
out" vesicles during membrane isolation.
This would lead to a drastic decrease in
accessible sites which are relevant for a
specific immune response against the
cell-surface pattern. On the other hand,
it cannot be excluded that rearrangement
of the methylated membrane during
isolation may occur, possibly including
conformational shifts in the methylated
membrane proteins, thus altering the
immunogenic specificity of the surface
structures which are originally respon-
sible for the effect of tumour protection.
In the light of these results, one may
expect that chemical modification of
isolated tumour-specific surface antigens
might still improve the immune response
specific for tumour protection.
The authors thank Dr H. P. Kulas for performing
the iodination experiment and Miss S. Glock for
excellent technical assistance.
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